Join our scientific talent community

Similar documents
1. The evidence: key facts & figures good reasons to invest in Belgium

1. What are the key strengths and weaknesses of the UK s innovation system in relation to business-university collaboration?

Molecular Biotechnology Master s Degree Program

EBiSC the first European bank for induced pluripotent stem cells


Groundbreaking Collaborative Clinical Trial Launched

POSTGRADUATE MASTERS DEGREES 2015 BIOSCIENCE, BIOTECHNOLOGY, BIODIVERSITY AND CONSERVATION

Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform

Curriculum Vitae. Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details. Education

THE BIOTECH & PHARMACEUTICAL INDUSTRY

Increasing Innovation in R&D - Seizing early stage external growth opportunities

Even we will get to use your product someday. Enough reason for us to deliver.

WHAT WILL YOU DISCOVER?

Zuyd University of Applied Sciences. Together we create the future

Master of Science in BIOINFORMATICS. > information. > insight. > innovation

Queen Mary, University of London An Overview

What Lies Ahead? Trends to Watch: Health Care Product Development in North America

shutterstock.com Interim Management and Strategic Transactions for International Life Science Companies TCG: experienced, connected, proven success

JOHN REID PhD, MBA. (302)

MAASTRICHT SCHOOL OF MANAGEMENT. Executive Master of Business Administration. your globally networked management schools

Master of Science in Biomedical Sciences

What do Birmingham postgraduates do?

Profile of Biomedical Research and Biotechnology Commercialization. San Francisco Oakland San Jose Consolidated Metropolitan Statistical Area

ONCOLOGY DERMATOLOGY A-DERMA AVÈNE DUCRAY ELANCYL GALÉNIC KLORANE RENÉ FURTERER

THE VIRAL HEPATITIS CONGRESS September 2015, Kap Europa, Frankfurt, Germany THE VIRAL HEPATITIS CONGRESS. Scientific Programme

The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder

Translational research infrastructure in Neurosciences /Bruxelles

Education is the best provision for old age.

Production in an Innovation Economy: The Globalization of Biomanufacturing and Implications for the Geography of Innovation

Orphan Pharma: pathfinders for an increasingly specialised industry

Competitive Advantages for Pharma Investing in Belgium

Executive MBA Incoming Students 2013

MOLOGEN AG German Equity Forum 2015

Rabobank Young Farmers Master Class

A Cost Effective Way to De Risk Biomarker Clinical Trials: Early Development Considerations

PharmD Postdoctoral Fellowship Program

A career on the science park

FLORIDA A&M UNIVERSITY AND BRISTOL-MYERS SQUIBB PHARMACEUTICAL INDUSTRY RESIDENCY PROGRAM

TOMORROW S HEALTHCARE STARTS HERE

MSC IN MEDICINAL CHEMISTRY

Taking Strategic Partnerships to the Next Level: An Alternative Approach to Licensing Your Development Asset

Bring your career into focus

The Commercialization of Technology Concepts into Medical Products

Shaping the Future of Healthcare

The College of Science Graduate Programs integrate the highest level of scholarship across disciplinary boundaries with significant state-of-the-art

ABLYNX COMPLETES 40 MILLION (~US$50 MILLION) SERIES C FINANCING ONE OF THE TWO LARGEST PRIVATE PLACEMENTS IN EUROPEAN BIOTECH THIS YEAR

Isaac A. Vargas Head of Inward Investment

QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES

Ready for your next career step?

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups

Hong Kong Poised to be the Asia s Biotechnology Hub

Automating Cell Biology Annual general meeting, September 7, Phase Holographic Imaging

Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM Alliance. Innovation PRELIMINARY. Management

Nuevas tecnologías basadas en biomarcadores para oncología

Personalized medicine in China s healthcare system

UNIVERSITY OF MIAMI SCHOOL OF BUSINESS ADMINISTRATION MISSION, VISION & STRATEGIC PRIORITIES. Approved by SBA General Faculty (April 2012)

Presented at: Jefferies 2015 Global Healthcare Conference

New York Bio Conference Mark J. Alles Chief Executive Officer

Inviting Possibilities. Healthcare. Cover Page- Healthcare Sector Report.indd 1

Data Centres. FDI and Market Trends 24 th June 2010

combining innovative business IT services and consumer technology to inspire the new digital economy The Atos Samsung Alliance

Early Phase Clinical Drug Development

Regulatory Affairs Graduate & Postgraduate Program. Novartis Pharma AG Novartis Animal Health AG

White Paper CLINICAL RESEARCH IN BELGIUM AN INTRODUCTION

The Sage Group and Talentmark Consulting Announce Strategic Alliance for Services to the Global Healthcare & Life Sciences Industry

Healthcare Coalition on Data Protection

Curriculum Vitae. CV Chairman ITERA Life-Sciences Forum: Personal data:

combining innovative business IT services and consumer technology to inspire the new digital economy The Atos Samsung Alliance

whatever your business...make it Navan Business & Technology Park

The UK s European university. MSc FORENSIC SCIENCE. Canterbury. Graduate study

Genetic Testing in Research & Healthcare

Bioethics Education in Professional Science Master s Programs at California State University Channel Islands

DEAN OF THE SCHOOL OF HEALTH SCIENCES

Brainport : a career gateway to Europe

Roles of Universities in Technology Transfer. CENG 109 Class 23

Institute for OneWorld Health

The Role of Research Institutions in the Formation of the Biotech Cluster in Massachusetts

Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis

FOCUS MONASH. Strategic Plan

The Private Health Insurance Market in Europe

IT Help Desk Engineer / Audio Visual Technician

The Texas Biotechnology Industry

Holland Image POSitive and negative Aspects. Top 3 associations with Holland. NBTC Holland Marketing. 1. japan 47% 1. germany 56% 2.

The Evolution of Data Platforms in IMI. Anthony Rowe, Janssen R&D IT 08 April 2016 Med-e-Tel Luxembourg

MSc program Pharmaceutical Design and Engineering. Peter Heegaard, Head of Studies DTU Veterinary

Why Atlanta For Your Business?

Transcription:

Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into exciting territories that are expected to change the healthcare landscape. Territories that go far beyond medicine, paving the way for an era of total solutions and tools for disease prevention, interception and management. For an era of intense connectivity and collaboration with the world s best scientific minds in inspiring hotspots around the world. 1

Research & Development, an exciting area to be in! You will soon find an air of excitement where everyone feels the sense of energy and urgency, that is authentic and comes straight from the hearts of talented people. People willing to make a difference for people s lives. Willing to push the boundaries of what science can do. Janssen Research & Development in Belgium is looking for people alike, new innovators to join us and take the next step in science. Janssen Belgium is the flagship R&D site of Janssen in Europe and the largest R&D center of Johnson & Johnson worldwide for small molecules. Belgium forms, together with the research centers in other European countries (France, Netherlands, Spain and UK), the United States and Asia Pacific, one global R&D organization, Janssen Research & Development. The campus developed over the years as a worldwide center of excellence investing in first-class research and development competences in the field of genomics, biotechnology, biomarkers, individualized diagnoses, vaccine platforms and drug delivery technologies. More than 1,800 employees are continually searching for innovative molecules following the example, energy and spirit of Dr. Paul Janssen. Focused R&D efforts Our long-term research and development efforts in Belgium focus on small molecules, vaccines and diagnostics in 3 therapeutic areas where we can make most impact: Oncology, Neuroscience, Infectious Diseases; and on Global Public Health. Every day our people are dedicated to the discovery and development of a new generation of small molecules for the fight against Alzheimer, mood disorders, hepatitis, HIV, different types of cancers. Recently, the site also entered into large-molecule research. The Janssen Campus has state-of-the-art expertise in the field of biomarker research, molecular diagnostics, imaging, preclinical development and safety, pharmaceutical development and many other areas. It houses the largest CTC (Circulating Tumor Cell) diagnostic and P3 laboratory in the world. The Campus is a pioneer in the implementation of new technologies in both development and in production. Technologies that are not available on any other site in the world. NEUROSCIENCE INFECTIOUS ONCOLOGY GLOBAL PUBLIC DISEASES HEALTH Collaboration DNA Today s medical challenges are far more complex than ever before. We encourage an environment where experience and knowledge is shared within and across teams, both locally and globally. Our seamless global network allows you to access the right resources wherever they may be. We never limit the search for new medicines to our own four walls. We have access to early-stage pioneering innovations in all leading hotspots around the world. The Johnson & Johnson Innovation Centers in Boston, California, London and Shanghai provide access to and collaboration with the best science and technology in the field of medical device and diagnostics, consumer healthcare products, and pharmaceuticals. The entrepreneurial scientist Janssen is a place where the entrepreneurial scientist will thrive people with that rare combination of a passion for deep research or development, a pioneering spirit, and the business savvy of an entrepreneur. Our scientists are active members of both the scientific communities in which they operate and the broader Johnson & Johnson and Janssen community. Janssen Campus Belgium is committed to creating opportunities for people as they engage in a scientific community of learning and socialize around their shared passion. Discover the Campus experience The Janssen Campus in Belgium is a great place to work, grow, collaborate across disciplines and thrive in a diverse, international and welcoming environment. We are fortunate to have world-class facilities that will help you achieve your career goals. We provide the environment to cultivate great dynamism and vibrancy on the campus. By investing in a robust and engaged community, we enrich the lives of our people and contribute to a vibrant campus community that develops leaders in all field people determined to have a positive impact. BOSTON CALIFORNIA THE JOHNSON & JOHNSON INNOVATION CENTERS www.jnjinnovation.com LONDON SHANGHAI 2 3

A career in science As a company, it is our responsibility to nurture our scientists professional passion by providing the best possible work environment one with flexibility, individual challenge, and personal fulfillment. You will have the benefit of working with and learning from the most respected scientists in your field. Whether you are a seasoned leader in your field or just beginning your scientific career, we welcome your interest in the scientific career path offered by Janssen Research & Development. It demonstrates our strong commitment to talent development by expanding opportunities and career options, and recognizing the importance of both scientific and management career paths. The Janssen scientific career framework has 2 career tracks: a scientific career track and a management career track. Discover the scientific career framework. YOUR SCIENTIFIC CAREER OPTIONS Whatever your career goals are, we provide a unique framework to grow, develop and excel. Vice President Scientific VP, Fellow Senior Director Sr. Scientific Director/Sr. Scientific Director & Fellow DEVELOP YOUR CAREER Discover your career options at the Janssen Campus Why work at Janssen R&D in Belgium? Director Scientific Director/Scientific Director & Fellow YOUR WORK HAS IMPACT YOUR WORK IS LEADING EDGE YOU GET THE BEST OF BOTH WORLDS Principal Scientist/Associate Director Senior Scientist Scientist Senior Associate Scientist Associate Scientist GROW YOUR SKILLS AND EXPERIENCE EXCEL PERSONALLY AND PROFESSIONALLY YOU COLLABORATE WITH THE BEST AND BRIGHTEST YOUR WORK ENVIRONMENT IS INSPIRING AND HONORS DIVERSITY AND INCLUSION YOUR CAMPUS LIES IN THE MIDDLE OF EUROPE AND A DYNAMIC LIFE SCIENCES ECOSYSTEM Assistant Scientist p.5 4 FOR MORE INFORMATION ON CAREER OPPORTUNITIES www.janssenjobs.be 5

Booming life sciences in Belgium Belgium is a world-class player in human healthcare. World leaders with bases in Belgium include GSK, UCB, Baxter, Janssen, Amgen, Genzyme, MSD, Pfizer and Roche. Janssen plays a key role as a major contributor to the Belgian life sciences industry. The life sciences climate in the country is very positive. The development of the life science sector in Belgium has created several biotechnology clusters comprising universities, companies and organizations active in the life science industry. Belgium has always proved to be a region that shows new ingenious ways of putting science to good use for the benefit of millions of people worldwide. By way of illustration: the Flanders region only comprises 13,500 km 2 (2/3 of Silicon Valley) and houses no less than 115 companies with pharma or biotech activities, employing over 10,000 employees and generating a total turnover of close on 2.9 billion. p.6 6 +140 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES BIG IN BIOPHARMA SEVERAL WORLD-RENOWNED UNIVERSITIES, RESEARCH CENTERS Also Wallonia is further consolidating its position as a scientific innovator, with high-tech companies having taken over the role previously played by heavy industry. What s more, all key biotech sectors are represented in Wallonia in the form of either companies or research centers. More than 100 innovative companies, particularly specializing in biopharmacy, cell therapy, radiopharmacy, diagnostics, biotechnology products, services (CRO, CMO) and medical devices and equipment are developing their businesses in this region. CLINICAL EXCELLENCE STRONG TRACK RECORD OF INTERNATIONAL SUCCESS HIGHLY QUALIFIED STAFF EXCELLENT QUALITY OF LIFE VERY GOOD LANGUAGE SKILLS 300 KM DISTANCE TO LONDON, PARIS, ROTTERDAM, AMSTERDAM, COLOGNE, LUXEMBOURG 11 MILLION PEOPLE 1 HOUR DRIVE BETWEEN BRUSSELS AND JANSSEN Working in Belgium The high quality of life in Belgium makes it an attractive country for expats. But there is more, exciting cities, lowest real estate costs in Europe, one of the best and most accessible healthcare systems in the world, a developed transport network, a multicultural and multilingual environment, education and excellent food. The country has a population of 11 million people. There are three official languages (Dutch, French and German). However, English is widely spoken all over the country. One in every ten inhabitants of Belgium is a foreign national. Belgium was one of the founder members of the European Union (EU) and hosts the headquarters of the EU and the North Atlantic Treaty Organization (NATO). Flanders is the northern part of Belgium, nestled between the Netherlands and France. Some of Europe s leading cities London, Paris, Rotterdam, Amsterdam, Cologne and Luxembourg are all situated within a radius of 300 km of Brussels. Brussels is an international metropolis, only 1 hour away from our Campus. A mosaic of languages, cultures, and traditions. The European School of Mol welcomes children from other European or overseas countries who live and work in the area. The school has 4 linguistic sections: a German, English, French and Dutch speaking section. 7

Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse - Belgium Whose life will you touch? Take the next step in science at Janssen Research & Development Belgium. JOIN OUR SCIENTIFIC TALENT COMMUNITY Responsible Publisher: Tim De Kegel, Turnhoutseweg 30, 2340 Beerse - Belgium janssenbelgium.be 8